Extramedullary plasmacytoma in relapse digital illustration

Extramedullary plasmacytoma in relapse Save


ICD-10 code: C90.22

Disease category: C90.2: Extramedullary plasmacytoma

Understanding Extramedullary Plasmacytoma in Relapse

Extramedullary plasmacytoma (EMP) is a rare type of cancer that affects the plasma cells outside the bone marrow. It mainly develops in soft tissues such as the lungs, throat, stomach, and other organs. Unfortunately, relapse is a common occurrence in patients with EMP.

Relapse refers to when cancer returns after a period of remission or improvement. The reason why EMP relapses are frequent is still unclear, but studies suggest that it may be due to the tumor cells' resistance to treatment.

When EMP relapses, it can be challenging to treat. The cancer may have spread to other parts of the body, and the patient may have already received radiation or chemotherapy during their initial treatment. Additionally, the tumor cells may have mutated, making them harder to kill.

  1. Signs and Symptoms of EMP Relapse
  2. The symptoms of EMP relapse may vary depending on the location of the tumor. Common signs of relapse include:

    • Swelling or lumps in the affected area
    • Pain or discomfort
    • Difficulty breathing or swallowing
    • Unexplained weight loss
  3. Diagnosing EMP Relapse
  4. Doctors may use similar methods to diagnose EMP relapse as they did during the initial diagnosis. These methods include:

    • MRI or CT scans to take detailed images of the affected area
    • Biopsies to collect tissue samples for examination
    • Blood tests to check for abnormal levels of proteins produced by plasma cells
  5. Managing EMP Relapse
  6. There is no definitive cure for extramedullary plasmacytoma, and treatment options for relapse depend on the patient's overall health, the location of the tumor, and the extent of the cancer's spread.

    However, doctors may recommend radiation therapy, chemotherapy, or a combination of both to help manage the symptoms and prevent the cancer from spreading further.

In conclusion, extramedullary plasmacytoma is a rare and challenging cancer to treat. When it relapses, it can be even more difficult to manage. Therefore, it is essential to be aware of the signs and symptoms of relapse and seek medical attention promptly. Regular follow-up appointments with your doctor can help catch any potential relapses early and improve the chances of successful treatment.

Treatment of Extramedullary plasmacytoma in relapse:

Treatment Options for Extramedullary Plasmacytoma in Relapse

Extramedullary plasmacytoma (EMP) is a rare type of cancer that develops in the soft tissues outside the bone marrow. While the disease has a relatively low incidence rate, there is a high chance of relapse after initial treatment. In this article, we will discuss the treatment options available for patients with extramed...

To see full information about treatment please Sign up or Log in